Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Number of holders
-
199
-
Total 13F shares, excl. options
-
55,625,309
-
Shares change
-
+1,290,886
-
Total reported value, excl. options
-
$4,289,793,406
-
Value change
-
+$92,816,537
-
Put/Call ratio
-
64.52%
-
Number of buys
-
88
-
Number of sells
-
-100
-
Price
-
$77.12
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q3 2018
246 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock as of Q3 2018.
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) has 199 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55,625,309 shares
of 58,643,980 outstanding shares and own 94.85% of the company stock.
Largest 10 shareholders include FMR LLC (8,698,886 shares), WELLINGTON MANAGEMENT GROUP LLP (7,867,379 shares), Vanguard Group Inc (4,251,439 shares), BlackRock Inc. (3,285,842 shares), Capital International Investors (3,096,422 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,830,017 shares), BB BIOTECH AG (2,197,931 shares), STATE STREET CORP (1,561,981 shares), Clearbridge Investments, LLC (1,506,662 shares), and Woodford Investment Management Ltd (1,317,459 shares).
This table shows the top 199 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.